Les Funtleyder, portfolio manager for E Squared Capital Management, joins 'The Exchange' to discuss big cap pharma's Q1 performance, the dollar weakness contributing to biotech gains, and investment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results